XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer
- Daniel R. Principe
- , Rui Xiong
- , Yangfeng Li
- , Thao N.D. Pham
- , Suneel D. Kamath
- , Oleksii Dubrovskyi
- , Kiira Ratia
- , Fei Huang
- , Jiong Zhao
- , Zhengnan Shen
- , Dinesh Thummuri
- , Zhou Daohong
- , Patrick W. Underwood
- , Jose Trevino
- , Hidayatullah G. Munshi
- , Gregory R.J. Thatcher
- , Ajay Rana
Research output: Contribution to journal › Article › peer-review
37
Link opens in a new tab
Scopus
citations